Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

od Albitar, Adam Z., Ma, Wanlong, Albitar, Maher
izdano v J Vis Exp (2017)

Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer

od Albitar, Ferras, Diep, Kevin, Ma, Wanlong, Albitar, Maher
izdano v J Cancer (2015)

Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations

od Lee, Tai-Sung, Ma, Wanlong, Zhang, Xi, Kantarjian, Hagop, Albitar, Maher
Izdano 2009

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits

od Ma, Wanlong, Brodie, Steven, Agersborg, Sally, Funari, Vincent A., Albitar, Maher
izdano v Mol Diagn Ther (2017)

BCR-ABL Truncation due to Premature Translation Termination as a Mechanism of Resistance to Kinase Inhibitors

od Ma, Wanlong, Kantarjian, Hagop, Yeh, Chen-Hsiung, Zhang, Zhong J., Cortes, Jorge, Albitar, Maher
Izdano 2009

Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling

od Lee, Tai-Sung, Kantarjian, Hagop, Ma, Wanlong, Yeh, Chen-Hsiung, Giles, Francis, Albitar, Maher
Izdano 2011

A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies

od Batenchuk, Cory, Albitar, Maher, Zerba, Kim, Sudarsanam, Sucha, Chizhevsky, Vladislav, Jin, Chelsea, Burns, Virginia
izdano v J Clin Pathol (2018)

Ubiquitin-Proteasome System Profiling in Acute Leukemias and its Clinical Relevance

od Ma, Wanlong, Kantarjian, Hagop, Zhang, Xi, Wang, Xiuiang, Estrov, Zeev, O’Brien, Susan, Albitar, Maher
Izdano 2010

Dysregulation of ubiquitin-proteasome pathway and apolipoprotein A metabolism in sickle cell disease–related pulmonary arterial hypertension

od Anjum, Fatima, Lazar, Jason, Soh, James, Albitar, Maher, Gowda, Satish, Hussain, M. Mahmood, Wadgaonkar, Raj
Izdano 2013

Clinical Correlation of Circulating Heat Shock Protein 70 in Acute Leukemia

od Yeh, Chen-Hsiung, Tseng, Richard, Hannah, Alison, Estrov, Zeev, Estey, Elihu, Kantarjian, Hagop, Albitar, Maher
Izdano 2009

Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System

od Albitar, Maher, Ma, Wanlong, Lund, Lars, Albitar, Ferras, Diep, Kevin, Fritsche, Herbert A., Shore, Neal
izdano v J Cancer (2016)

Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias

od Ma, Wanlong, Kantarjian, Hagop, Zhang, Xi, Yeh, Chen-Hsiung, Zhang, Zhong J., Verstovsek, Srdan, Albitar, Maher
Izdano 2009

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer

od Albitar, Maher, Sudarsanam, Sucha, Ma, Wanlong, Jiang, Shiping, Chen, Wayne, Funari, Vincent, Blocker, Forrest, Agersborg, Sally
izdano v Oncotarget (2018)

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK...

od Albitar, Adam, Ma, Wanlong, DeDios, Ivan, Estella, Jeffrey, Ahn, Inhye, Farooqui, Mohammed, Wiestner, Adrian, Albitar, Maher
izdano v Oncotarget (2017)

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy

od Albitar, Maher, Ma, Wanlong, Lund, Lars, Shahbaba, Babak, Uchio, Edward, Feddersen, Soren, Moylan, Donald, Wojno, Kirk, Shore, Neal
izdano v J Cancer (2017)

B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia

od Landgren, Ola, Albitar, Maher, Ma, Wanlong, Abbasi, Fatima, Hayes, Richard B., Ghia, Paolo, Marti, Gerald E., Caporaso, Neil E.
izdano v N Engl J Med (2009)

Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study

od Richardson, Paul G., Chanan-Khan, Asher A., Alsina, Melissa, Albitar, Maher, Berman, David, Messina, Marianne, Mitsiades, Constantine S., Anderson, Kenneth C.
Izdano 2010

Resistance to Imatinib in Patients with Chronic Myelogenous Leukemia and the Splice Variant BCR-ABL1(35INS)

od Berman, Ellin, Jhanwar, Suresh, Hedvat, Cyrus, Arcila, Maria E., Wahab, Omar Abdel-, Levine, Ross, Maloy, Molly, Ma, Wanlong, Albitar, Maher
izdano v Leuk Res (2016)

Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma

od Richardson, Paul G., Badros, Ashraf Z., Jagannath, Sundar, Tarantolo, Stefano, Wolf, Jeffrey L., Albitar, Maher, Berman, David, Messina, Marianne, Anderson, Kenneth C.
Izdano 2010

Circulating Ki-67 Index in Plasma as a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia

od Bruey, Jean-Marie, Kantarjian, Hagop, Ma, Wanlong, Estrov, Zeev, Yeh, Chenhsiung, Donahue, Amber, Sanders, Heather, O'Brien, Susan, Keating, Michael, Albitar, Maher
Izdano 2010